P. Rhodes Jason's Insider Trades & SAST Disclosures
P. Rhodes Jason's most recent trade in Dyne Therapeutics Inc was a trade of 1,111,111 Common Stock done at an average price of $13.5 . Disclosure was reported to the exchange on Jan. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern P. Rhodes Jason.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 13.50 per share. | 27 Jan 2025 | 1,111,111 | 1,958,427 | - | 13.5 | 14,999,999 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 14 Nov 2024 | 583 | 5,697,508 | - | 33.1 | 19,297 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 14 Nov 2024 | 123 | 1,458,568 | - | 33.1 | 4,071 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 14 Nov 2024 | 72 | 847,316 | - | 33.1 | 2,383 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 14 Nov 2024 | 4 | 15,962 | - | 33 | 132 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 01 Mar 2024 | 29,435 | 1,458,691 | - | 30.1 | 884,522 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 01 Mar 2024 | 17,099 | 847,388 | - | 30.1 | 513,825 | Common Stock |
| Dyne Therapeutics Inc | Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 26 Feb 2024 | 272,923 | 5,878,544 | - | 24.4 | 6,653,863 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 26 Feb 2024 | 152,244 | 5,700,521 | - | 24.8 | 3,780,219 | Common Stock |
| Dyne Therapeutics Inc | Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 26 Feb 2024 | 136,312 | 6,216,250 | - | 23.6 | 3,215,600 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 26 Feb 2024 | 64,783 | 6,151,467 | - | 24.0 | 1,553,496 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 26 Feb 2024 | 40,455 | 1,514,874 | - | 24.4 | 986,293 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 26 Feb 2024 | 25,779 | 5,852,765 | - | 24.7 | 636,226 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 26 Feb 2024 | 23,505 | 880,022 | - | 24.4 | 573,052 | Common Stock |
| Dyne Therapeutics Inc | P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 26 Feb 2024 | 22,567 | 1,488,486 | - | 24.8 | 560,339 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 26 Feb 2024 | 20,205 | 1,564,932 | - | 23.6 | 476,636 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 26 Feb 2024 | 13,109 | 864,697 | - | 24.8 | 325,496 | Common Stock |
| Dyne Therapeutics Inc | P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 26 Feb 2024 | 11,736 | 909,107 | - | 23.6 | 276,852 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 26 Feb 2024 | 9,603 | 1,555,329 | - | 24.0 | 230,280 | Common Stock |
| Dyne Therapeutics Inc | P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 26 Feb 2024 | 5,580 | 903,527 | - | 24.0 | 133,808 | Common Stock |
| Dyne Therapeutics Inc | P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 26 Feb 2024 | 3,821 | 1,511,053 | - | 24.7 | 94,302 | Common Stock |
| Dyne Therapeutics Inc | P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 25.25 per share. | 26 Feb 2024 | 2,430 | 5,698,091 | - | 25.3 | 61,358 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 26 Feb 2024 | 2,216 | 877,806 | - | 24.7 | 54,691 | Common Stock |
| Dyne Therapeutics Inc | P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.25 per share. | 26 Feb 2024 | 360 | 1,488,126 | - | 25.3 | 9,090 | Common Stock |
| Dyne Therapeutics Inc | P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.25 per share. | 26 Feb 2024 | 210 | 864,487 | - | 25.3 | 5,303 | Common Stock |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 22.70 per share. | 21 Feb 2024 | 159,542 | 6,352,562 | - | 22.7 | 3,621,603 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 22.44 per share. | 21 Feb 2024 | 149,337 | 6,666,628 | - | 22.4 | 3,351,122 | Common Stock |
| Dyne Therapeutics Inc | Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 22.66 per share. | 21 Feb 2024 | 119,360 | 6,512,104 | - | 22.7 | 2,704,698 | Common Stock |
| Dyne Therapeutics Inc | P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 23.14 per share. | 21 Feb 2024 | 35,164 | 6,631,464 | - | 23.1 | 813,695 | Common Stock |
| Dyne Therapeutics Inc | P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 22.70 per share. | 21 Feb 2024 | 23,648 | 1,585,137 | - | 22.7 | 536,810 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 22.70 per share. | 21 Feb 2024 | 13,738 | 920,843 | - | 22.7 | 311,853 | Common Stock |
| Dyne Therapeutics Inc | Rhodes P. Jason | Director | Sale of securities on an exchange or to another person at price $ 23.88 per share. | 15 Feb 2024 | 175,793 | 7,150,324 | - | 23.9 | 4,197,937 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 22.71 per share. | 15 Feb 2024 | 166,029 | 6,819,475 | - | 22.7 | 3,770,519 | Common Stock |
| Dyne Therapeutics Inc | P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.14 per share. | 15 Feb 2024 | 162,707 | 6,985,504 | - | 23.1 | 3,765,040 | Common Stock |
| Dyne Therapeutics Inc | Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 23.40 per share. | 15 Feb 2024 | 3,510 | 6,815,965 | - | 23.4 | 82,134 | Common Stock |
| Dyne Therapeutics Inc | Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 24.45 per share. | 15 Feb 2024 | 2,113 | 7,148,211 | - | 24.5 | 51,663 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 24,900 | 24,900 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Purchase of securities on an exchange or from another person at price $ 10.70 per share. | 12 Dec 2022 | 934,581 | 934,581 | - | 10.7 | 10,000,017 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,200 | 19,200 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
| Replimune Group Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Disc Medicine Inc | Jason P. Rhodes | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2021 | 17,245 | 17,245 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 27 Sep 2021 | 51,294 | 29,645 | - | 25.7 | 1,318,256 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.59 per share. | 27 Sep 2021 | 16,556 | 0 | - | 24.6 | 407,112 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.24 per share. | 27 Sep 2021 | 13,089 | 16,556 | - | 25.2 | 330,366 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.71 per share. | 27 Sep 2021 | 95 | 662 | - | 25.7 | 2,442 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.60 per share. | 27 Sep 2021 | 30 | 608 | - | 24.6 | 738 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.25 per share. | 27 Sep 2021 | 24 | 638 | - | 25.3 | 606 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.77 per share. | 24 Jun 2021 | 26,858 | 4,092 | - | 25.8 | 692,131 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 26.39 per share. | 24 Jun 2021 | 4,092 | 0 | - | 26.4 | 107,988 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.78 per share. | 24 Jun 2021 | 50 | 616 | - | 25.8 | 1,289 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 26.38 per share. | 24 Jun 2021 | 8 | 608 | - | 26.4 | 211 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.82 per share. | 21 Jun 2021 | 59,978 | 155,708 | - | 24.8 | 1,488,654 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.08 per share. | 21 Jun 2021 | 34,162 | 59,281 | - | 25.1 | 856,783 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.76 per share. | 21 Jun 2021 | 33,261 | 118,651 | - | 24.8 | 823,542 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.69 per share. | 21 Jun 2021 | 28,331 | 30,950 | - | 25.7 | 727,823 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.20 per share. | 21 Jun 2021 | 25,208 | 93,443 | - | 25.2 | 635,242 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.12 per share. | 21 Jun 2021 | 3,796 | 151,912 | - | 25.1 | 95,356 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.82 per share. | 21 Jun 2021 | 111 | 897 | - | 24.8 | 2,755 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.08 per share. | 21 Jun 2021 | 63 | 719 | - | 25.1 | 1,580 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.75 per share. | 21 Jun 2021 | 61 | 829 | - | 24.8 | 1,510 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 21 Jun 2021 | 53 | 666 | - | 25.7 | 1,362 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.19 per share. | 21 Jun 2021 | 47 | 782 | - | 25.2 | 1,184 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.14 per share. | 21 Jun 2021 | 7 | 890 | - | 25.1 | 176 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 26.07 per share. | 12 Apr 2021 | 63,353 | 77,329 | - | 26.1 | 1,651,613 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.09 per share. | 12 Apr 2021 | 35,791 | 30,767 | - | 25.1 | 897,996 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 26.78 per share. | 12 Apr 2021 | 12,874 | 0 | - | 26.8 | 344,766 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 26.61 per share. | 12 Apr 2021 | 10,771 | 66,558 | - | 26.6 | 286,616 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 26.40 per share. | 12 Apr 2021 | 10,539 | 12,874 | - | 26.4 | 278,230 | Common Stock |
| Generation Bio Co | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.53 per share. | 12 Apr 2021 | 7,354 | 23,413 | - | 25.5 | 187,748 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 46.14 per share. | 26 Jan 2021 | 5,558 | 946,000 (2%) | 0% | 46.1 | 256,446 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 41.95 per share. | 18 Dec 2020 | 3,012 | 2,263,627 (6%) | 0% | 41.9 | 126,353 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 41.95 per share. | 18 Dec 2020 | 1,042 | 951,558 (2%) | 0% | 42.0 | 43,712 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 41.95 per share. | 18 Dec 2020 | 265 | 19,285 (0%) | 0% | 42.0 | 11,117 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.40 per share. | 15 Dec 2020 | 28,078 | 2,283,960 (6%) | 0% | 42.4 | 1,190,507 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.40 per share. | 15 Dec 2020 | 9,710 | 958,589 (2%) | 0% | 42.4 | 411,704 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.13 per share. | 15 Dec 2020 | 8,849 | 2,274,692 (6%) | 0% | 42.1 | 372,808 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 15 Dec 2020 | 8,053 | 2,266,639 (6%) | 0% | 42 | 338,226 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.13 per share. | 15 Dec 2020 | 3,060 | 955,385 (2%) | 0% | 42.1 | 128,918 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 15 Dec 2020 | 2,785 | 952,600 (2%) | 0% | 42 | 116,970 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.40 per share. | 15 Dec 2020 | 2,432 | 21,049 (0%) | 0% | 42.4 | 103,117 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.13 per share. | 15 Dec 2020 | 766 | 20,247 (0%) | 0% | 42.1 | 32,272 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 15 Dec 2020 | 697 | 19,550 (0%) | 0% | 42 | 29,274 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 43.12 per share. | 15 Dec 2020 | 349 | 2,283,611 (6%) | 0% | 43.1 | 15,049 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 43.12 per share. | 15 Dec 2020 | 120 | 958,469 (2%) | 0% | 43.1 | 5,174 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 44.09 per share. | 15 Dec 2020 | 70 | 2,283,541 (6%) | 0% | 44.1 | 3,086 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 43.13 per share. | 15 Dec 2020 | 30 | 21,019 (0%) | 0% | 43.1 | 1,294 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 44.08 per share. | 15 Dec 2020 | 24 | 958,445 (2%) | 0% | 44.1 | 1,058 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 15 Dec 2020 | 6 | 21,013 (0%) | 0% | 44 | 264 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 43.54 per share. | 10 Dec 2020 | 21,428 | 2,314,125 (6%) | 0% | 43.5 | 932,975 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 43.32 per share. | 10 Dec 2020 | 19,712 | 2,340,703 (6%) | 0% | 43.3 | 853,924 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 42.68 per share. | 10 Dec 2020 | 12,691 | 2,371,734 (6%) | 0% | 42.7 | 541,652 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 43.48 per share. | 10 Dec 2020 | 8,666 | 2,363,068 (6%) | 0% | 43.5 | 376,798 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 43.54 per share. | 10 Dec 2020 | 7,409 | 969,021 (2%) | 0% | 43.5 | 322,588 | Common Stock |
| Replimune Group Inc | Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 43.32 per share. | 10 Dec 2020 | 6,817 | 978,212 (2%) | 0% | 43.3 | 295,312 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges